IRSG staging
Also written as: IRSG — Intergroup Rhabdomyosarcoma Study Group staging
Intergroup Rhabdomyosarcoma Study Group staging system used for pediatric soft tissue sarcomas, particularly rhabdomyosarcoma.
Full Definition
The IRSG staging system is a post-surgical staging classification developed by the Intergroup Rhabdomyosarcoma Study Group specifically for rhabdomyosarcoma and other pediatric soft tissue sarcomas. Unlike pre-treatment staging systems, IRSG classification is based on the extent of disease after initial surgery and biopsy. Groups range from I (localized disease, completely resected) to IV (distant metastases), with each group having distinct treatment protocols and prognoses. This system is crucial for treatment planning in pediatric orthopedic oncology.
Usage
Usage note: Primarily used for pediatric soft tissue sarcomas, not adult bone tumors.
In Context
- "The pathology confirmed IRSG staging Group III disease requiring intensive chemotherapy." — Pediatric oncology note
- "IRSG staging is essential for determining treatment protocols in pediatric rhabdomyosarcoma." — Treatment guideline